Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
Clinical trial NCT01328535 · COMPLETED
Trial details
- NCT number
- NCT01328535
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-06-22
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.